Form 8-K - Current report:
SEC Accession No. 0001823239-21-000018
Filing Date
2021-08-10
Accepted
2021-08-10 16:18:11
Documents
15
Period of Report
2021-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20210805.htm   iXBRL 8-K 45832
2 EX-2.1 exhibit21to8-10x218xkproje.htm EX-2.1 837870
3 EX-99.1 exhibit991-q22021.htm EX-99.1 195286
7 image_0.jpg GRAPHIC 8145
  Complete submission text file 0001823239-21-000018.txt   1388034

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20210805.xsd EX-101.SCH 1899
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20210805_lab.xml EX-101.LAB 25848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20210805_pre.xml EX-101.PRE 13579
8 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20210805_htm.xml XML 12990
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 211160155
SIC: 2834 Pharmaceutical Preparations